Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 240,958
  • Shares Outstanding, K 20,147
  • Annual Sales, $ 79,180 K
  • Annual Income, $ -64,720 K
  • EBIT $ -70 M
  • EBITDA $ -62 M
  • 60-Month Beta 1.18
  • Price/Sales 3.01
  • Price/Cash Flow 8.26
  • Price/Book 1.87

Options Overview Details

View History
  • Implied Volatility 82.14% (-2.39%)
  • Historical Volatility 32.90%
  • IV Percentile 74%
  • IV Rank 41.12%
  • IV High 149.14% on 01/30/26
  • IV Low 35.35% on 01/22/26
  • Expected Move (DTE 14) 1.62 (13.54%)
  • Put/Call Vol Ratio 1.00
  • Today's Volume 4
  • Volume Avg (30-Day) 141
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 3,403
  • Open Int (30-Day) 2,579
  • Expected Range 10.37 to 13.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 02/28/26
See More
  • Average Estimate $0.27
  • Number of Estimates 2
  • High Estimate $0.31
  • Low Estimate $0.23
  • Prior Year $0.31
  • Growth Rate Est. (year over year) -12.90%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.09 +8.12%
on 03/30/26
12.69 -5.55%
on 03/12/26
-0.14 (-1.15%)
since 03/02/26
3-Month
11.09 +8.12%
on 03/30/26
21.01 -42.93%
on 01/23/26
-6.12 (-33.79%)
since 01/02/26
52-Week
11.09 +8.12%
on 03/30/26
36.45 -67.11%
on 04/24/25
-12.78 (-51.59%)
since 04/02/25

Most Recent Stories

More News
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date

Conference call to be on Thursday, April 9, 2026, at 5 p.m. ET

SLP : 11.99 (+0.25%)
Simulations Plus Announces Strategic Collaboration Programs for AI-Enabled Modeling

Co-development initiatives to advance next-generation workflows, accelerate adoption, and expand the role of AI within model-informed drug development

SLP : 11.99 (+0.25%)
Simulations Plus Convenes Industry and Regulatory Leaders to Define Responsible AI in MIDD

Expert panel at the 2026 ASCPT Annual Meeting brings together leaders with industry and regulatory experience to explore practical, accountable AI implementation

SLP : 11.99 (+0.25%)
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations

Extended projects support ongoing research into computational approaches and new approach methodologies for food and chemical safety assessment

SLP : 11.99 (+0.25%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 8, 2026 /PRNewswire/ --

SLP : 11.99 (+0.25%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Feb. 3, 2026 /PRNewswire/ --

SLP : 11.99 (+0.25%)
Simulations Plus to Participate in Upcoming Investor Conferences

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”, “SLP”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced...

SLP : 11.99 (+0.25%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Jan. 29, 2026 /PRNewswire/ --

SLP : 11.99 (+0.25%)
Rosen Law Firm Encourages Simulations Plus, Inc. Investors to Inquire About Securities Class Action Investigation - SLP

NEW YORK , Jan. 23, 2026 /PRNewswire/ --

SLP : 11.99 (+0.25%)
Simulations Plus Highlights Platform Innovation and Strategic Direction at 2026 Investor Day

Showcases platform momentum, strategic priorities, and long-term value creation outlook

SLP : 11.99 (+0.25%)

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 12.75
2nd Resistance Point 12.42
1st Resistance Point 12.21
Last Price 11.99
1st Support Level 11.67
2nd Support Level 11.34
3rd Support Level 11.13

See More

52-Week High 36.45
Fibonacci 61.8% 26.76
Fibonacci 50% 23.77
Fibonacci 38.2% 20.78
Last Price 11.99
52-Week Low 11.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.